In vitro activity of azthreonam, a monobactam antibiotic.

We studied the activity of azthreonam (SQ 26,776), a novel monocyclic beta-lactam compound, against a variety of clinical isolates. It was more potent than moxalactam, cefoperazone, cefamandole, cefoxitin, ticarcillin, tobramycin, or amikacin against strains of Klebsiella spp., Serratia spp., and th...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jacobus, N V, Ferreira, M C, Barza, M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1982
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185668/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6891198/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.5.832
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!